TELESCOPE REPORTS FIRST FISCAL QUARTER 2023 RESULTS

February 8, 2023 — Telescope is revenue-positive for a second consecutive quarter. Catch us at a series of upcoming investor events and technical conferences.
TELESCOPE PRESENTS 2022 FISCAL YEAR HIGHLIGHTS AND INVESTOR UPDATE

January 23, 2023 — Telescope reports revenue in first full year of operation, a new project with Aqualung Carbon Capture, and upcoming events.
TELESCOPE ANNOUNCES CLOSING OF $1.46 MILLION NON-BROKERED PRIVATE PLACEMENT

November 10, 2022 — Telescope intends to use the net proceeds from the Offering for working capital and general corporate purposes.
TAKEAWAYS FROM OUR PRESS RELEASE ON NRCAN PROJECT

October 31, 2022 — View PR highlights and watch the video on how this project supports Telescope’s goals
TELESCOPE ANNOUNCES ENGAGEMENT WITH NATURAL RESOURCES CANADA TO DEVELOP LITHIUM REFINEMENT TECHNOLOGY

October 24, 2022 — Telescope will collaborate with NRCan to build an autonomous, self-driving experimental platform for lithium refinement.
SECOND NOBEL PRIZE WON BY TELESCOPE INNOVATIONS ADVISOR

October 6, 2022 — K. Barry Sharpless, a member of Telescope’s Scientific Advisory Board, was awarded the 2022 Nobel Prize in Chemistry.
Telescope welcomes Dr. Jeffrey Sherman as Chief Operating Officer

September 6, 2022 — Dr. Sherman brings over thirty years of experience in the scientific instrument industry, including work with Micromeritics Instrument Corporation, ThermoFisher Scientific, and Mettler-Toledo.
Telescope upgrades US listing to OTCQB

September 1, 2022 — We anticipate that our OTCQB listing will provide greater liquidity and a more seamless trading experience for our U.S. shareholders.
Contextualizing our completed research project funded by Pfizer

August 13, 2022 —We are deploying our unique technology platforms to resolve critical bottlenecks in the chemical and pharmaceutical industry.
Telescope completes feasibility research project funded by Pfizer

August 10, 2022 — We created a proof-of-concept robotic workflow leveraging our proprietary in-situ analytical technology and automation tools.